ABOUT THE PRODUCT
IV Brincidofovir is a novel antiviral medication being developed by SymBio Pharmaceuticals for the treatment of various viral infections, including adenovirus infection following hematopoietic stem cell transplantation and Epstein-Barr virus associated lymphoproliferative disease. It is currently in clinical trials.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from SymBio Pharma USA, Inc.
SyB V-1901 & SyB L-1701/L-1702
Pharmaceutical
N/A
SymBio Pharma USA, Inc.
United States (US)